UltraPure Systems Group Buys Out Parent Company CBI

July 5, 2001
By Marialba Martinez
Caribbean Business

A local investment group spearheaded by UltraPure Systems Inc.'s general manager Cesar A. Roca finalized a stock buyout from parent company Chicago Bridge & Iron (CBI) last week.

The deal secures the jobs of the 125-employee work force that produces high purity process systems for the biopharmaceutical product manufacturing and delivery system industries in Puerto Rico.

Eighteen months ago, CBI invested $3 million to establish UltraPure Systems in Puerto Rico. They hired civil engineer Cesar A. Roca as general manager, bought a manufacturing facility in Vega Baja; hired qualified management and supervisors, purchased equipment, and trained production personnel.

"During the first 18 months of operation, UltraPure Systems registered $20.4 million in sales. Prior to the acquisition, the company was expected to exceed its first year sales by 25%. Right now, we are entering the buyout with a work backlog of more than $6 million in orders and a prospect list of about $20 million," said Cesar Roca, the new president and CEO of UltraPure Systems.

In 1999, CBI approached Roca, at the time working for its only industry competitor on the island, to establish UltraPure Systems as a subsidiary. CBI, with headquarters in the Netherlands, specializes in hydrocarbon-related businesses; power generation; combustion technology; and water storage & wastewater treatment.

But Puerto Rico looked like a good investment site to establish a biopharmaceutical manufacturing plant for high purity process systems because of its large number of targeted clients. CBI also established UltraPure Systems plants in Singapore and the U.S. (Texas & North Carolina), but those were geared towards the semiconductor industry. When the semiconductor industry took an unexpected dive in 1999 and the hydrocarbon industry expanded dramatically, CBI consulted Roca about a possible management buyout.

"CBI called me on May 31 and explained how the biopharmaceutical business, though extremely productive for Puerto Rico, was too small a segment to maintain the semiconductor business losses. They asked me for a preliminary proposal in seven days, which I presented at UltraPure Systems' Dallas headquarters on June 11. One week later, CBI's board of directors approved the sale and made a formal announcement," said Roca.

While the effective date of the sale is May 31, Roca still had to look for financing and renegotiate incentives with the Puerto Rico Industrial Development Co. (Pridco). In its commitment to save every job possible in Puerto Rico, the agency agreed to fast-paced renegotiation of its incentives package, granting UltraPure Systems tax exemption, job creation tax credits, and training incentives.

About $100,000 annually goes towards training orbital welding, a computerized fusion process, in which a clamp holds tubes to be welded and form a closed chamber for inert gases to pass through. The welding arc rotates — or orbits — around the weld. UltraPure Systems uses stainless steel tubes in various widths and lengths, accommodating their skills to the clients' needs.

Integrity Piping Solutions (IPS) is a third-party consultant hired by Abbott Pharmaceutical to monitor compliance with all procedures, documentation, and inspection of all systems manufactured and installed by UltraPure Systems. IPS Operations Vice President Joseph A. Tatarewitz said that UltraPure Systems is as up-to-date as any facility he has ever supervised.

"In 15 years working exclusively within the high purity process systems industry, I can compare UltraPure Systems craftsmen with the best I have seen. "This project's rejection rate has been extremely low, maybe three welds out of 900, when the average for a job is 5%," said Tatarewitz.

Roca is looking forward to continuing projects and beginning new ones for pharmaceutical companies such as Pharmacia, Lederle, OMJ Pharmaceutical, IPR Pharmaceuticals, Eli Lilly, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Novartis, ICM Pharmaceutical, and Amgen.

What we are really preparing for is to become a manufacturing plant for custom-engineered process skids for the biopharmaceutical industry. "No local company has been able to offer process skids manufactured in Puerto Rico and the island is one of the top producers of pharmaceuticals. We want to put UltraPure Systems and Puerto Rico on the global map as a manufacturer of quality process skids — to put the 'Made in Puerto Rico by UltraPure Systems' seal on process skids installed not only on the island, but anywhere in the world," said Roca.